Heather Raymon

Company: Artiva Biotherapeutics, Inc

Job title: Senior Vice President - Research & Early Development

Seminars:

Roundtable Discussion: Discussing the Persistence of NK Cells in an Autoimmune Context 11:00 am

Is short lived persistence advantageous in an autoimmune setting as opposed to oncology? Evaluating if NKs are efficacious in eradicating autoimmune cells and whether patients need re-dosing  Based on our understanding of NK biology can we predict what long term outcomes would look like in autoimmune patients?Read more

day: Pre-Conference Focus Day

Understanding Mechanisms Behind NK Targeting of Autoimmune Cells 1:30 pm

Sharing our current knowledge on the approaches to NK cell targeting of tumorigenic and pathogenic B-cell  ADCC enhancement as an effective mechanism in the clinicRead more

day: Pre-Conference Focus Day